Skip to main content
. Author manuscript; available in PMC: 2024 Mar 14.
Published in final edited form as: Eur Respir J. 2024 Feb 1:2300846. doi: 10.1183/13993003.00846-2023

Table 3. Features present on initial CTPA at time of PE diagnosis in patients with subsequent diagnosis of CTEPH and a randomly selected control group of patients not diagnosed with CTEPH.

CTEPH +ve
(n=36)
CTEPH -ve
(n=36)
Demographics:
Age, years (mean ± SD) 69.9 ± 13.9 68.5 ± 11.95
Sex M/F n, (%) 18 (50)/18 (50) 16 (44)/20(56)
Features suggestive of PH:
PA ≥ 30mm n, (%) 24 (67) 11 (31)
RV:LV ≥1 n, (%) 28 (78) 13 (36)
RVOTH ≥6mm n, (%) 16 (44) 3 (8)
All 3 features suggestive of PH present n, (%) 13 (36) 2 (6)
Features suggestive of CTEPD:
Dilated bronchial arteries, yes/no (%)* 10 (28) 2 (6)
Arterial webs or bands, yes/no (%) 4 (11) 1 (3)
Attenuated or Occluded vessels combined, n (%) 13 (36) 1 (3)
Mosaic parenchymal perfusion pattern yes/no n, (%) 8 (22) 2 (6)
2 or more features suggestive of CTEPD n, (%) 12 (33) 1 (3)
Features suggestive of CTEPH at index event:
3 features of PH and ≥ 2 features of CTEPD n, (%) 7 (19) 0 (0)

PA=pulmonary artery; RV:LV=right to left ventricular ratio; RVOTH=right ventricular outflow tract hypertrophy; PH=pulmonary hypertension; CTEPD=chronic thromboembolic pulmonary disease; CTEPH=chronic thromboembolic pulmonary hypertension.

CTPA at the time of diagnosis of sufficient diagnostic quality were available for review in 36/41 of CTEPH +ve patients and are compared to a randomly selected control group of 36 patients not diagnosed as having CTEPH during the conduct of the study. PA pulmonary artery diameter; RV:LV ratio of internal right ventricular to left ventricular diameter; RVOTH thickness of right ventricular outflow tract.

*

assessment of bronchial artery size was not possible due to lack of contrast opacification in 9 (25%) of CTEPH +ve patients and 6 (17%) of CTEPH -ve patients